Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease
- 15 May 2014
- journal article
- review article
- Published by Wiley in Biotechnology Journal
- Vol. 9 (7) , 882-894
Abstract
Huntington's disease (HD) is a fatal inherited neurodegenerative disorder characterized by progressive loss of neurons in the striatum, a sub‐cortical region of the forebrain. The sub‐cortical region of the forebrain is associated with the control of movement and behavior, thus HD initially presents with coordination difficulty and cognitive decline. Recent reprogramming technologies, including induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs), have created opportunities to understand the pathological cascades that underlie HD and to develop new treatments for this currently incurable neurological disease. The ultimate objectives of stem cell‐based therapies for HD are to replace lost neurons and to prevent neuronal dysfunction and death. In this review, we examine the current understanding of the molecular and pathological mechanisms involved in HD. We discuss disease modeling with HD‐iPSCs derived from the somatic cells of patients, which could provide an invaluable platform for understanding HD pathogenesis. We speculate about the benefits and drawbacks of using iNSCs as an alternative stem cell source for HD treatment. Finally, we discuss cell culture and engineering systems that promote the directed differentiation of pluripotent stem cell‐derived NSCs into a striatal DARPP32+ GABAergic MSN phenotype for HD. In conclusion, this review summarizes the potentials of cell reprogramming and engineering technologies relevant to the development of cell‐based therapies for HD.Keywords
Funding Information
- Korea University (K1131491)
- Republic of Korea Ministry of Science, ICT and Future Planning (2012M3A9C6050131, 20100020349)
- Republic of Korea Ministry of Health and Welfare (A120392, A120340)
This publication has 121 references indexed in Scilit:
- Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned MiceCell Stem Cell, 2012
- Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of DiseaseNeurotherapeutics, 2012
- Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem CellsCell Stem Cell, 2010
- Long-Term, Stable Differentiation of Human Embryonic Stem Cell-Derived Neural Precursors Grafted into the Adult Mammalian NeostriatumStem Cells, 2009
- Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression SignaturesCell Stem Cell, 2009
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Transcriptional signatures in Huntington's diseaseProgress in Neurobiology, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Identification of Intrinsic Determinants of Midbrain Dopamine NeuronsCell, 2006